Gujarat Themis Biosyn Closes Trading Window from Jan 1, 2026 for Q4 FY26 Results
Gujarat Themis Biosyn Limited will close its trading window from January 1, 2026. The window will reopen 48 hours after the board declares financial results for the quarter ending December 31, 2025. The exact date of the board meeting will be announced later.
The closure of the trading window is a standard procedural requirement mandated by SEBI regulations. It does not provide any new information about the company's performance or future prospects, hence its impact on the stock is considered low.
The announcement is a routine regulatory disclosure regarding the closure of the trading window, which is a standard procedure before financial results are declared. It does not contain any new financial information or business updates that would significantly impact the stock's sentiment.
Gujarat Themis Biosyn Limited has announced the closure of its trading window from Thursday, January 1, 2026. This closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct for preventing insider trading.
The trading window will remain closed until 48 hours after the Board of Directors declares the financial results for the quarter ending December 31, 2025. The company will intimate the date of the Board Meeting for considering these financial results in due course.
The registered office of Gujarat Themis Biosyn Limited is located in Vapi, Gujarat, with a corporate office in Mumbai. The announcement was made on December 26, 2025.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.